81 Research Studies Confirm Natural Immunity to COVID ‘Equal’ or ‘Superior’
- Thread starter exlib
- Start date
Nano silver safety and efficacy - https://duckduckgo.com/?q=Nano+silver+safety+and+efficacy&t=h_&ia=web
Colloidal silver safety and efficacy - https://duckduckgo.com/?q=Colloidal+silver+safety+and+efficacy&t=h_&ia=web
Last edited:
The NFL and its doctors seem to believe in natural immunity
https://profootballtalk.nbcsports.c...-cases-wont-be-tested-for-rest-of-season/amp/
https://profootballtalk.nbcsports.c...-cases-wont-be-tested-for-rest-of-season/amp/
Funded by Gates foundation:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02465-5/fulltext
Findings
We identified a total of 65 studies from 19 different countries. Our meta-analyses showed that protection from past infection and any symptomatic disease was high for ancestral, alpha, beta, and delta variants, but was substantially lower for the omicron BA.1 variant. Pooled effectiveness against re-infection by the omicron BA.1 variant was 45·3% (95% uncertainty interval [UI] 17·3–76·1) and 44·0% (26·5–65·0) against omicron BA.1 symptomatic disease. Mean pooled effectiveness was greater than 78% against severe disease (hospitalisation and death) for all variants, including omicron BA.1. Protection from re-infection from ancestral, alpha, and delta variants declined over time but remained at 78·6% (49·8–93·6) at 40 weeks. Protection against re-infection by the omicron BA.1 variant declined more rapidly and was estimated at 36·1% (24·4–51·3) at 40 weeks. On the other hand, protection against severe disease remained high for all variants, with 90·2% (69·7–97·5) for ancestral, alpha, and delta variants, and 88·9% (84·7–90·9) for omicron BA.1 at 40 weeks.
Interpretation
Protection from past infection against re-infection from pre-omicron variants was very high and remained high even after 40 weeks. Protection was substantially lower for the omicron BA.1 variant and declined more rapidly over time than protection against previous variants. Protection from severe disease was high for all variants. The immunity conferred by past infection should be weighed alongside protection from vaccination when assessing future disease burden from COVID-19, providing guidance on when individuals should be vaccinated, and designing policies that mandate vaccination for workers or restrict access, on the basis of immune status, to settings where the risk of transmission is high, such as travel and high-occupancy indoor settings.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02465-5/fulltext
Findings
We identified a total of 65 studies from 19 different countries. Our meta-analyses showed that protection from past infection and any symptomatic disease was high for ancestral, alpha, beta, and delta variants, but was substantially lower for the omicron BA.1 variant. Pooled effectiveness against re-infection by the omicron BA.1 variant was 45·3% (95% uncertainty interval [UI] 17·3–76·1) and 44·0% (26·5–65·0) against omicron BA.1 symptomatic disease. Mean pooled effectiveness was greater than 78% against severe disease (hospitalisation and death) for all variants, including omicron BA.1. Protection from re-infection from ancestral, alpha, and delta variants declined over time but remained at 78·6% (49·8–93·6) at 40 weeks. Protection against re-infection by the omicron BA.1 variant declined more rapidly and was estimated at 36·1% (24·4–51·3) at 40 weeks. On the other hand, protection against severe disease remained high for all variants, with 90·2% (69·7–97·5) for ancestral, alpha, and delta variants, and 88·9% (84·7–90·9) for omicron BA.1 at 40 weeks.
Interpretation
Protection from past infection against re-infection from pre-omicron variants was very high and remained high even after 40 weeks. Protection was substantially lower for the omicron BA.1 variant and declined more rapidly over time than protection against previous variants. Protection from severe disease was high for all variants. The immunity conferred by past infection should be weighed alongside protection from vaccination when assessing future disease burden from COVID-19, providing guidance on when individuals should be vaccinated, and designing policies that mandate vaccination for workers or restrict access, on the basis of immune status, to settings where the risk of transmission is high, such as travel and high-occupancy indoor settings.
Indeed.I was fine with natural immunity for 2 years until omicron came along.
After getting omicron I was around a lot of people with covid and haven't gotten it again.I think omicron natural immunity is as good as the originals natural immunity
Shot out to the vaccine though my vaccinated mom breezed though covid with no problems while she lost a few friends and relatives around her age before the vaccine was available.
Last edited:
GWB told us antibodies were out in 40 days!!!
No problems with people that have that opinion.The problem with GWB is that he will lie his ass off with made up bull shit to support that opinion.